{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-074127","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2022-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.291257+00:00","generated_at":"2026-06-26T23:13:18.836863+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Minerva Neurosciences receives Nasdaq delisting notice for equity shortfall","bullets":["Notice received March 8, 2022: stockholders' equity in 2021 10-K fails Nasdaq Rule 5450(b)(1).","Company has 45 days to submit a plan to regain compliance with the Rule.","If plan accepted, Nasdaq may grant up to 180 days from notice date for evidence of compliance.","If plan rejected or extension denied, Company may appeal to Nasdaq Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-074127","json":"https://secwatch.observer/filing/0001193125-22-074127.json","markdown":"https://secwatch.observer/filing/0001193125-22-074127.md","text":"https://secwatch.observer/filing/0001193125-22-074127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/0001193125-22-074127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/d316228d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T23:13:18.836863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}